The efficacy assessments of alkylating drugs induced by nano-Fe3O4/CA for curing breast and hepatic cancer

2017 ◽  
Vol 173 ◽  
pp. 82-86 ◽  
Author(s):  
Kui He ◽  
Ying Ma ◽  
Bin Yang ◽  
Caishuang Liang ◽  
Xiaoming Chen ◽  
...  
Keyword(s):  
Hepatic Cancer ◽  
Alkylating Drugs ◽  
Nano Fe3o4

Hepatic Cancer

1959 ◽  
Vol 37 (5) ◽  
pp. 669-688 ◽  
Author(s):  
W. Stanley Hartroft
Keyword(s):  
Hepatic Cancer

Advantage of microwave coagulo-necrotic therapy for hepatic cancer with chronic failure

1998 ◽  
Vol 16 ◽  
pp. 53-57
Author(s):  
Takatsugu Oida ◽  
Hiroshi Miyake ◽  
Shigeru Fujisaki ◽  
Ken-ichiro Mori ◽  
Satoshi Hata ◽  
...  
Keyword(s):  
Hepatic Cancer

Synthesis of Chalcone Derivatives by Phthalhydrazide-Functionalized TiO2-Coated Nano-Fe3O4 as a New Heterogeneous Catalyst

2020 ◽  
Vol 17 ◽  
Author(s):  
Forough Motamedi Nia ◽  
Mahnaz Farahi ◽  
Bahador Karami ◽  
Raziyeh Keshavarz
Keyword(s):  
Heterogeneous Catalyst ◽  
Significant Loss ◽  
Magnetic Nanocatalyst ◽  
Chalcone Derivatives ◽  
Ft Ir ◽  
Nano Fe3o4

Abstract:: Phthalhydrazide immobilized on TiO2-coated nano Fe3O4 (Fe3O4-P) was synthesized and characterized by FT-IR, XRD, SEM, EDS and VSM analysis. The resulting magnetic nanocatalyst was used as a catalyst for the synthesis of chalcone derivatives which affords the desired products in good to excellent yields. This catalyst can be isolated readily after completion of the reaction by an external magnetite field and reused several times without significant loss of activity.

scholarly journals Clinical application of thioredoxin reductase as a novel biomarker in liver cancer

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Xuping Wu ◽  
Qi Wang ◽  
Yousheng Lu ◽  
Jinye Zhang ◽  
Hanwei Yin ◽  
...  
Keyword(s):  
Liver Cancer ◽  
Tumor Markers ◽  
Clinical Application ◽  
Thioredoxin Reductase ◽  
Superior Performance ◽  
Percutaneous Ablation ◽  
Hepatic Cancer ◽  
Diagnostic Efficiency ◽  
Malignant Diseases ◽  
Clinical Method

AbstractHepatic cancer is often amenable to surgery, including percutaneous ablation, trans-arterial chemoembolization. However, in metastatic cases, surgery is often not an effective option. Chemotherapy as a conventional clinical method for treatment of malignant diseases may be useful in such cases, but it is likewise not always able to slow or halt progression, therefore novel approaches for treatment of hepatic cancer are needed. Current research suggests that molecular tumor markers (TM) can play a crucial role for diagnosis and prognostic evaluation of malignancies, and TM such as AFP, CEA, CA19-9 have been reported in many malignant diseases. Thioredoxin reductase (TrxR), a type of anti-oxidant biomarker, has become a TM of significant interest. However, little is known about the above TM and TrxR activity in liver cancer. Therefore, this paper aimed to assess these TM with regards to diagnosis and and monitoring treatment efficacy in both primary and metastatic liver cancer. Our results showed TrxR had superior performance for discriminating between liver cancer patients and healthy controls than AFP, CEA, and CA19-9. TrxR also exhibited superior performance for assessing benefits of chemotherapy regardless if patients had PLC or MLC. Meanwhile, due to diagnostic efficiency of unresponsive chemotherapy patients, TrxR also showed a higher activity levels than other general markers in liver metastasis patients. Our results suggest that application of TrxR in combination with other tumor markers may maximize the efficiency of diagnosis and assessment of therapeutic efficiency, and provide new insights for the clinical application of TrxR as a candidate biomarker for liver cancer.

scholarly journals The Protective Effect of Ammi visnaga Extract against Human Hepatic Cancer

2021 ◽  
pp. 101540
Author(s):  
Mohammed Waleed Arafah ◽  
Bader Almutairi ◽  
Mohammed Al-Zharani ◽  
Abdullah A. Alkahtane ◽  
Fatimah O. Al-Otibi ◽  
...  
Keyword(s):  
Protective Effect ◽  
Hepatic Cancer ◽  
Ammi Visnaga
Sign in / Sign up

Export Citation Format

Share Document